SLN360

Drug identity checked against registry records

Also recorded as Zerlasiran

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
Evaluate SLN360 in Participants With Elevated Lipoprotein(a) at High Risk of Atherosclerotic Cardiovascular Disease EventsNCT05537571SLNPhase 2Completed2024-01-11Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.